You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 125 No. 4, April 1970 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (44)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Mechanisms Responsible for Plasma Levels of Nafcillin Lower Than Those of Oxacillin

Allan C. Kind, MD; Thelma E. Tupasi, MD; Harold C. Standiford, MD; William M. M. Kirby, MD

Arch Intern Med. 1970;125(4):685-690.


Abstract

Nafcillin sodium is known to give lower plasma levels than oxacillin sodium after both oral and parenteral administration. In the present study this difference was present in healthy volunteers within five minutes after a rapid intravenous infusion, and in uremic patients, plasma levels of nafcillin were only one half those of oxacillin after one hour. The factor mainly responsible was a much larger apparent volume of distribution for nafcillin, which seemed to result from a selective sequestration of the antibiotic in the liver and possibly in other tissues. With a continuous intravenous infusion, plasma levels of the two antibiotics were almost equal, in contrast to much higher levels of ampicillin than penicillin G, and of cephaloridine than cephalothin sodium, when studied similarly. These results were due to differences in renal and nonrenal clearances.



Author Affiliations

Seattle

From the Department of Medicine, University of Washington School of Medicine, Seattle.


Footnotes

Received for publication Sept 24, 1969; accepted Nov 24.

Reprint requests to Department of Medicine, University of Washington School of Medicine, Seattle 98105 (Dr. Kirby).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Faropenem Transport across the Renal Epithelial Luminal Membrane via Inorganic Phosphate Transporter Npt1
Uchino et al.
Antimicrob. Agents Chemother. 2000;44:574-577.
ABSTRACT | FULL TEXT  

Hepatic Sinusoidal Membrane Transport of Anionic Drugs Mediated by Anion Transporter Npt1
Yabuuchi et al.
J. Pharmacol. Exp. Ther. 1998;286:1391-1396.
ABSTRACT | FULL TEXT  

Guide to Drug Usage in Adult Patients With Impaired Renal Function: A Supplement
Bennett et al.
JAMA 1973;223:991-997.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1970 American Medical Association. All Rights Reserved.